813 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Stocks making the biggest moves premarket: HON, LLY, AMGN, TM, HD & more https://www.cnbc.com/2017/12/13/stocks-making-the-biggest-moves-premarket-hon-lly-amgn-tm-hd-more.html Dec 13, 2017 - Names on the move ahead of the open.
3 Reasons Why Gilead Sciences Stock Is a Buy Now https://www.fool.com/investing/2017/09/15/3-reasons-why-gilead-sciences-stock-is-a-buy-now.aspx?source=iedfolrf0000001 Sep 15, 2017 - A splashy acquisition that puts this company on the cutting edge of cancer treatment isn't the only reason to buy shares. Gilead Sciences' margins are among the best in biotech, and its valuation arguably makes it a bargain.
The Only 2 Biotech Stocks With a Higher Dividend Yield Than the S&P 500 https://www.fool.com/investing/2017/09/04/the-only-2-biotech-stocks-with-a-higher-dividend-y.aspx?source=iedfolrf0000001 Sep 04, 2017 - 99% of biotech stocks don't pay a dividend -- but these two have a market-topping yield.
5 Compelling Reasons Why AbbVie's Dividend Will Keep on Growing https://www.fool.com/investing/2017/09/13/5-compelling-reasons-why-abbvies-dividend-will-kee.aspx?source=iedfolrf0000001 Sep 13, 2017 - AbbVie's great dividend should get even better.
Pharma Industry Outlook - February/March 2017 http://www.zacks.com/commentary/104804/pharma-industry-outlook-february-march-2017?cid=CS-ZC--104804 Feb 27, 2017 - Pharma Industry Outlook - February/March 2017
Amgen's Q1 Results Highlight the Need for an Acquisition https://www.fool.com/investing/2017/04/27/amgens-q1-results-highlight-the-need-for-an-acquis.aspx?source=iedfolrf0000001 Apr 27, 2017 - Is it time for Amgen to spend some of its cash stockpile? The big biotech's Q1 results say "yes."
Teva Investors Get Headache Relief https://www.wsj.com/articles/teva-investors-get-headache-relief-1537200489?mod=rss_Technology Sep 17, 2018 - A new migraine drug is a big win amid the turnaround of generics business.
3 Stocks That Are Absurdly Cheap Right Now https://www.fool.com/investing/2017/07/23/3-stocks-that-are-absurdly-cheap-right-now.aspx?source=iedfolrf0000001 Jul 23, 2017 - While the market just keeps going up, there's still some value to be found.
Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN) http://www.zacks.com/stock/news/224867/biotech-earnings-battle-gilead-gild-vs-amgen-amgn?cid=CS-ZC-FT-224867 Jul 25, 2016 - Amgen and Gilead Sciences are both reporting earnings this week. Which company is the better bet right now?
Is the System Rigged Against Biosimilars? https://www.fool.com/investing/2017/08/26/is-the-system-rigged-against-biosimilars.aspx?source=iedfolrf0000001 Aug 26, 2017 - Pfizer and Amgen are encountering problems getting traction for their biosimilars. Is the system rigged against them?

Pages: 1234567...82

<Page 2>